DD Support Board and Research Team

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

New Clinic Brings Specialized Care to Long Island Listen, when it comes to healthcare, especially something as life-altering as food allergies, you're not just looking for any run-of-the-mill clinic. You're looking for the right place with the right people who get it. And folks in Long Island are getting something worth celebrating—a new clinic from Latitude Food...

ELEGOO's 2026 Holiday Strategy: Deep Discounts Welcome to the world of sharp deals and crafty creations as ELEGOO kicks off its Black Friday and Cyber Monday extravaganza. This time, they're slashing prices by up to 54% on their impressive lineup of 3D printers and captivating accessories. Yeah, it's that time of year when wallets might take a hit, but for a good reason....

Pivotal Leadership Change at Carnegie Mellon's SEI Big moves are coming out of Pittsburgh, folks. Carnegie Mellon University just shook things up by naming Jason M. Brown as the next director and CEO of their Software Engineering Institute (SEI). This signal-fire moment catches my eye as the SEI stands at the cutting edge of software, artificial intelligence, and...

Tackling the Age-Old Heating Puzzle Ah, the charm of an older home—from the creaky floors to the vintage architecture, it's something else. But, let's face it, keeping these houses warm can feel like patching up an old ship. Our man Reid Sittler, HVAC aficionado from Massillon, Ohio, shares some no-nonsense insights on how to stop your precious heat from slipping...

Challenging Times Meet Strategic Moves On the face of it, Alamo Group's (NYSE: ALG) third-quarter results for 2026 paint a mixed picture. Sales dipped by 4% compared to the same quarter last year, settling at $403.1 million. No investor likes to see a decline, that's for sure. Yet, peeling back a few layers, there's more to the story than just the raw numbers. Let's chew...

LITEON Smashes Q3 Records, Financials Speak Volumes You don't find numbers like these under every rock. LITEON Technology is rolling in it after clinching third quarter revenues of NT$57.4 billion, marking a significant 9% growth compared to the previous quarter and a whopping 28% surge year-over-year. That's the kind of financial football that gets investors holding onto...

A Rough Road Ahead for Chemours Investors Well, folks, Chemours Company isn’t exactly living its best life right now. Following a tumble of 18.63% in its stock price after less-than-stellar second-quarter earnings, the legal hounds are circling the wagons. Investors who picked up shares between February 20, 2026, and August 4, 2026, might be feeling a bit sore right...

A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...

Decades of Corporate Drama Unfold in Court A pesky legal storm is brewing from the heart of Yangzhou, China, as Jiangsu Muyang Group battles former execs in a lawsuit that reeks of corporate intrigue. You can't make this stuff up—downright Shakespearean treachery unfolding at a feed machinery powerhouse! Muyang's courtroom escapades haven't exactly flown under the...

Spyre Therapeutics Unveils Key Research at UEGW Congress Spyre Therapeutics, Inc. (NASDAQ: SYRE), a prominent player in the biotechnology sector, is gearing up to showcase innovative research at an upcoming significant event in the medical community, the UEGW Congress. This clinical-stage company is on an ambitious path towards revolutionizing the treatment for...

LGI Homes Expands Its Footprint in the Portland Area LGI Homes (NASDAQ: LGIH) has made a significant move in the homebuilding landscape by unveiling two new vibrant communities. This exciting development aims to fulfill the diverse needs of homebuyers looking for quality and affordability. With Dove Landing and Copper Heights now open, residents can look forward to an...

Overview of Stride, Inc. Legal Challenges In a significant legal development, Stride, Inc. (NYSE: LRN) has come under scrutiny due to a class action lawsuit recently filed against it. This lawsuit highlights alleged violations of federal securities laws, impacting numerous investors who have sustained losses exceeding $100,000. Details of the Allegations The class action...

Canadian National Railway Surpasses Earnings Expectations Canadian National Railway (NYSE: CNI) recently announced its third quarter earnings, revealing an earnings per share (EPS) of C$1.72. This figure exceeded the average analyst expectation by C$0.02, where analysts had estimated an EPS of C$1.70. The revenue for the quarter recorded at C$4.11 billion, surpassing the...

Understanding Dividend Income from Applied Materials Applied Materials, Inc. (NASDAQ: AMAT) is expected to announce its financial results for the fourth quarter soon, and investors are undoubtedly excited to see how the company is performing. Analysts predict earnings of around $2.30 per share, reflecting growth compared to $2.13 in the same quarter last year. The...